Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHA Guidelines Rate Aspirin, Antioxidants, Omega-3s For Prevention

This article was originally published in The Tan Sheet

Executive Summary

Aspirin therapy to prevent stroke should be considered for all women, while antioxidant vitamin supplements are not recommended to prevent cardiovascular disease, the American Heart Association says in the update to its guidelines for preventing CVD in women

You may also be interested in...



Vitamins E And C Trial Shows No CVD-Prevention Benefits In “Healthy” Men

A study finding no link between vitamin E or vitamin C supplementation and cardiovascular disease prevention in men was conducted using subjects largely regarded as healthy - a population that supplement industry stakeholders have called the true measuring stick for evaluating nutrient benefits

Vitamins E And C Trial Shows No CVD-Prevention Benefits In “Healthy” Men

A study finding no link between vitamin E or vitamin C supplementation and cardiovascular disease prevention in men was conducted using subjects largely regarded as healthy - a population that supplement industry stakeholders have called the true measuring stick for evaluating nutrient benefits

Vitamins E And C Trial Shows No CVD-Prevention Benefits In “Healthy” Men

A study finding no link between vitamin E or vitamin C supplementation and cardiovascular disease prevention in men was conducted using subjects largely regarded as healthy - a population that supplement industry stakeholders have called the true measuring stick for evaluating nutrient benefits

Topics

UsernamePublicRestriction

Register

OM009724

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel